Fenofibrate lowers abdominal and skeletal adiposity and improves insulin sensitivity in OLETF rats-Reference-Cited by-同舟云学术

Fenofibrate lowers abdominal and skeletal adiposity and improves insulin sensitivity in OLETF rats

Published:2002-08 Issue:2 Volume:296 Page:293-299
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Lee H.J.,Choi S.S.,Park M.K.,An Y.J.,Seo S.Y.,Kim M.C.,Hong S.H.,Hwang T.H.,Kang D.Y.,Garber A.J.,Kim D.K.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference35 articles.

1. High fat fed hamster, a unique animal model for treatment of diabetic dyslipidemia with peroxisome proliferator activated receptor alpha selective agonists;Wang;Eur. J. Pharmacol.,2001

2. The effect of micronized fenofibrate on the plasma levels of glycated LDL-C Lp(a) and insulin resistance in patients with type 2 diabetes mellitus;Park;J. Korean Diabetes Assoc.,2000

3. Effects of comicronised fenofibrate on lipid and insulin sensitivity in patients with polymetabolic syndrome X;Idzior-Walus;Eur. J. Clin. Invest.,2000

4. Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat;Lee;Diabetes,1994

5. Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats;Kramer;Metabolism,2001

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of different levels of fenofibrate on growth performance, carcase characteristics, abdominal fat, serum constitutes, immune system, caeca and microbial flora of broilers;Italian Journal of Animal Science;2022-02-18

2. Protective effect of fenofibrate against high‐fat–high‐fructose diet induced non‐obese NAFLD in rats;Fundamental & Clinical Pharmacology;2020-08-19

3. In vivo evidence that bezafibrate prevents oxidative stress and mitochondrial dysfunction caused by 3-methylglutaric acid in rat liver;Biochimie;2020-04

4. An In Vivo/Ex Vivo Study Design to Investigate Effects of Chronic Conditions and Therapeutic Compounds on Adipose Stem Cells in Animal Models;Methods in Molecular Biology;2020

5. Administration of Fenofibrate Markedly ElevatesFabp3in Rat Liver and Plasma and Confounds Its Use as a Preclinical Biomarker of Cardiac and Muscle Toxicity;Lipids;2018-10